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Understanding the molecular foundations of embryonic stem cell (ESC) self-renewal and pluripotency will
facilitate therapeutic exploitation of these remarkable cells. Here we discuss the emerging roles of micro-
RNAs in the establishment and maintenance of ESC identity and summarize our current understanding of
the mechanisms controlling microRNA expression and function in ESCs.Embryonic stem cells (ESCs) derived from the inner cell mass
(ICM) of mammalian blastocyst-stage embryos are characterized
by two properties: the ability to differentiate into any type of
specialized cell, known as pluripotency, and their unlimited
capacity for self-renewal. ESCs can be isolated and cultured
in vitro without losing their ability to contribute to all cell types,
and thus hold big promise for future studies of tissue formation
and drug development as well as cell replacement therapy.
Furthermore, the capacity to artificially reprogram differentiated
cells back into a stem cell-like state provides great potential for
regenerative medicine. Pluripotency and self-renewal are intri-
cate biological processes that are coordinately regulated by
a complex set of factors. ESC self-renewal requires that the
unique molecular program of the pluripotent state be maintained.
In contrast, to differentiate into various cell lineages, ESCs must
shift to alternative molecular programs that inhibit self-renewal
and promote the differentiated state. How cells switch between
pluripotency and differentiation is still incompletely understood.
However, several ‘‘stemness’’ factors required to ensure appro-
priate ESC behavior have been identified. A core network of tran-
scription factors and RNA-binding proteins, including Oct4, Sox2,
Nanog, Klf4, c-Myc, Tcf3, and Lin28, cooperate in intricate regu-
latory circuits to ensure appropriate ESC behavior (Marson et al.,
2008). Some of these factors share a substantial fraction of their
target genes and participate in autologous feedback loops to
control one another’s transcription. Notably, several of these
key transcription factors directly regulate microRNA (miRNA)
expression in ESCs. By occupying miRNA gene promoter
regions, these factors not only activate expression of ESC miR-
NAs but also play a role in silencing a subset of miRNAs that are
expressed in differentiated cell types. When artificially expressed
in differentiated cells, a subset of these regulatory factors can
reprogram cells back to a stem cell-like state, called induced
pluripotent stem cells (iPSCs) (Takahashi and Yamanaka, 2006;
Yu et al., 2007). Numerous lines of evidence now implicate
miRNAs as central players in ESC biology (Gangaraju and Lin,
2009). In this article, we discuss the emerging roles of miRNAs
in the self-renewal and differentiation of ESCs and summarize
our current understanding of the complex mechanisms control-
ling miRNA expression and function in embryonic stem cells.miRNA Biogenesis and Function
miRNAs are now recognized as an abundant class of genome-
encoded, small RNAs that repress gene expression at the post-
transcriptional level via base pairing to complementary sites
located in target messenger RNAs (mRNAs) (Winter et al.,
2009). miRNAs are evolutionarily conserved and have been
implicated in the regulation of a variety of diverse biological
processes. Dysregulated miRNA expression is associated with
several diseases, most notably cancer (Esquela-Kerscher and
Slack, 2006). The biogenesis of most of the several hundred
known miRNAs begins with the transcription of long, capped,
and polyadenylated primary transcripts (pri-miRNA) by RNA
polymerase II. Hairpin-shaped pri-miRNAs are cleaved in the
nucleus by the Microprocessor complex, comprised of the
RNase III enzyme Drosha and the double-stranded RNA binding
domain (dsRBD) protein DGCR8. The Microprocessor specifi-
cally cleaves pri-miRNAs at the base of the stem loop to produce
60–70 nt long precursors (pre-miRNA) that are subsequently
transported by Exportin-5 to the cytoplasm where they are
recognized by a heterotrimeric complex composed of the RNase
Dicer, the double-stranded RNA-binding protein TRBP, and
Argonaute (Ago) proteins. Dicer further cleaves pre-miRNAs
22 nt from the Drosha cleavage site, thereby generating a
mature miRNA duplex. This complex identifies the guide strand
of the 22 nt RNA duplex and separates the two RNA strands.
The guide strand of the miRNA remains associated with the
Ago protein in the miRNA-induced silencing complex (miRISC),
which in turn recognizes target mRNAs based on complemen-
tarity between the miRNA and the mRNA target (Winter et al.,
2009). Nucleotides 2–7 (from the 50-end) of the mature miRNA,
also called the ‘‘seed’’ motif, form the critical region for target
mRNA recognition that hybridizes nearly perfectly with the
target to nucleate the miRNA-mRNA interaction. In this way a
particular miRNA sequence is thought to guide the regulation
of several hundred different mRNAs. Additionally, an individual
mRNA may be simultaneously targeted by multiple different
miRNAs. Thus, miRNA-mediated gene regulation represents an
extensive mechanism for modulating gene expression. Although
still controversial, mRNA-mediated posttranscriptional gene
silencing may involve translational repression, degradation,Cell Stem Cell 7, July 2, 2010 ª2010 Elsevier Inc. 31
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protein degradation.
Global Loss of miRNAs Results in Proliferation Defects
and a Failure to Silence the ESC Program
The overall function of the miRNA pathway in mouse ESCs has
been evaluated by analyzing the phenotypes caused by genetic
ablation of essential components of the miRNA biogenesis
machinery. Dicer1-knockout mice die at early stages of develop-
ment and Dicer-deficient mouse ESCs are defective in differen-
tiation (reviewed by Gangaraju and Lin, 2009). Specifically, loss
of Dicer in ESCs leads to an acute loss of proliferative potential
that can eventually be rescued by the accumulation of compen-
satory factors, either mutations or stable changes in gene
expression. Interestingly, these cells display an altered cell cycle
profile, with a slight increase of cells in the G1 and G0 (nondi-
viding) phases of the cell cycle. Because Dicer is required for
the maturation of other types of small RNAs besides miRNAs,
a more accurate interpretation of the role of miRNAs in ESCs
came from Dgcr8-knockout studies. Mice deficient in DGCR8
also arrest in early development and, although less severe than
Dicer1-deficient cells,Dgcr8-knockout ESCs also exhibit a prolif-
eration defect and cannot efficiently silence the ESC program.
Even under stringent differentiation conditions, DGCR8-deficient
ESCs do not fully downregulate pluripotency markers and retain
the ability to produce ESC colonies (Gangaraju and Lin, 2009).
Similar to miRNA-deficient mouse ESCs, Dicer- and Drosha-
knockdown human ESCs, which reportedly appear morpholog-
ically similar to their wild-type counterparts, are unable to
downregulate stem cell-specific markers and display defects in
self-renewal. Specifically,Dicer- andDrosha-knockdown human
ESCs are characterized by G1-S and G2-M transition delays (Qi
et al., 2009). Altogether, these findings indicate that miRNAs are
required for proper function of both proliferation and differentia-
tion pathways in mouse and human ESCs.
ESCs Are Characterized by a Defined miRNA Signature
Small RNA profiling in different mammalian tissues and cell types
has revealed a plethora of miRNAs, with more than 500 identified
so far, some of which are cell type specific and others of which
display a more widespread expression profile. Both mouse and
human ESCs express only a very limited repertoire of miRNAs
whose levels decrease as the stem cells differentiate (Gangaraju
and Lin, 2009). Indeed, the ESC-specific miR-290 family (which
includes miR-290, miR-291a, miR-291b, miR-292, miR-293,
miR-294, miR-295) and miR-302 cluster (miR-302a, miR-302b,
miR-302c, miR-302d, miR-367) in mice, and miR-371 family
(miR-371, miR-372, miR-373) that is homologous to the mouse
miR-290 family, and miR-302 family in humans, represent the
majority of the total miRNA molecules expressed in undifferenti-
ated ESCs (Marson et al., 2008). Interestingly, many of the ESC-
specific miRNAs are cotranscribed as polycistronic transcripts,
suggesting common upstream regulation and coordinate
expression patterns. Indeed, the transcription of these miRNAs
seems to be directly regulated by a core set of pluripotency tran-
scription factors (Marson et al., 2008). Significantly, members of
this set of ESC miRNAs possess the same or similar seed motif,
suggesting common sets of target mRNAs (Gangaraju and Lin,
2009). Furthermore, ESC-expressed miRNAs are not present or32 Cell Stem Cell 7, July 2, 2010 ª2010 Elsevier Inc.exist only at very low levels in somatic cells. Conversely, a number
of miRNAs that appear to be widely expressed in most differenti-
ated cell types, notably the let-7 family, are present at low levels in
ESCs (Viswanathan et al., 2008).
ESC-Specific miRNAs Regulate the Cell Cycle
ESCs are highly proliferative and exhibit an expedited cell cycle,
which is critical for fast growth during early mammalian embryo-
genesis. The average cell cycle length of mouse ESCs is around
12 hr as opposed to 24 hr for somatic cells. The cell cycle of
a dividing cell is composed of four consecutive phases: G1, S,
G2, and M. ESCs exhibit a unique cell cycle structure in which
a shortened G1 phase is maintained. This pattern is accom-
plished by an unrestricted G1 to S phase transition (G1-S). The
G1 restriction point normally requires the sequential activation
of the Cdk4/6 and the Cdk2 kinases by the D and E type cyclins,
respectively. In mouse ESCs, the cyclin D-Cdk4/6 complex is
absent, and progression though the G1-S transition is primarily
controlled by the constitutive activity of the cyclin E-Cdk2
complex. Upstream inhibitors including Cdkn1a, Cdkn1b, Rb1,
Rbl1, Rbl2, and Lats2 modulate the activity of the Cdk-Cyclin
complexes (Wang et al., 2008).
The proliferation defect of Dicer1 and Dgcr8 mutant ESCs
suggests that miRNAs are normally required to promote the
G1-S transition, perhaps by repressing proteins that directly or
indirectly maintain ESC self-renewal. As predicted from a study
of Dicer1-knockout ESCs, where it was shown that reintroduc-
tion of miR-290 cluster miRNAs can partially rescue the prolifer-
ation defects of miRNA-deficient ESCs (Sinkkonen et al., 2008),
Blelloch and colleagues identified a set of miRNAs that partially
rescue the proliferation and cell cycle defects of Dgcr8-deficient
mouse ESCs (Wang et al., 2008). These miRNAs include
members of the highly expressed miR-290 and miR-302 clusters
that have been dubbed embryonic stem cell-cell cycle regulating
(ESCC) miRNAs. ESCC miRNAs share a similar seed sequence,
suggesting that common sets of genes are regulated by these
miRNAs (Wang et al., 2008). In support of this model, cyclin E-
Cdk2 upstream inhibitors including Cdkn1a, Rb1, Rbl1, Rbl2,
and Lats2 are upregulated in Dgcr8-knockout cells and are pre-
dicted targets of ESCC miRNAs. Moreover, a direct miRNA-
mediated repression has been shown for Cdkn1a, Rbl2, and
Lats2 (Sinkkonen et al., 2008; Wang et al., 2008). Hence,
ESCC miRNAs directly repress key regulators of the cell cycle
to ensure a fast G1-S transition. The miRNA redundancy high-
lights the importance of speeding up the G1-S transition in early
embryonic cells.
Interestingly, the promoters of ESCC miRNA clusters are
bound by core ESC transcription factors. Oct4, Sox2, Nanog,
c-Myc, and Tcf3 directly bind and upregulate the expression of
ESCC cell miRNAs (Marson et al., 2008). In turn, the ESCC
miRNAs were shown to maintain the ESC program by inhibiting
the epigenetic silencing of pluripotency factors. Specifically,
the mir-290 cluster was shown to indirectly repress the expres-
sion of de novo DNA methyl-transferases by silencing the tran-
scriptional repressor Rbl2 (reviewed by Gangaraju and Lin,
2009; Sinkkonen et al., 2008). These findings highlight the intri-
cacy of regulatory circuits that ensure appropriate ESC behavior.
Analogous to mouse ESCs, their human counterparts are also
characterized by an expedited cell cycle progression via
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are differentially expressed between human and mouse ESCs,
the role of miRNAs in cell cycle progression seems to be
conserved. For instance, miR-92a has been identified as a regu-
lator of the G1-S transition in human ESCs by repressing the
Cdkn1c checkpoint gene (Sengupta et al., 2009). Work by the
Ruohola-Baker group demonstrated that two miRNAs, miR-
195 and miR-372, could partially reverse the cell cycle delay in
Dicer-knockdown human ESC lines. Whereas miR-372 was
shown to regulate the G1-S checkpoint inhibitor Cdkn1a, miR-
195 was shown to regulate the G2-M checkpoint inhibitory
kinase WEE1, one of the three kinases that negatively regulate
the G2 cyclin B-Cdk complex in mammalian cells (Qi et al., 2009).
The miRNA Pathway Regulates ESC Differentiation
During mammalian development, ESCs must shift to alternative
molecular programs that inhibit self-renewal and orchestrate
differentiation into highly specialized cell types. miRNA-deficient
ESCs have defects in both normal proliferation as well as ESC
differentiation (Gangaraju and Lin, 2009). Interestingly, ESCC
miRNAs do not rescue the differentiation defects of Dicer1- or
Dgcr8-knockout cells, suggesting that different miRNAs underlie
the two phenotypes (Sinkkonen et al., 2008; Wang et al., 2008).
The let-7 family of miRNAs is broadly expressed across differen-
tiated tissues and is tightly regulated during ESC differentiation
(Viswanathan et al., 2008). Therefore, it has been proposed
that let-7 is a prodifferentiation factor with ‘‘anti-stemness’’
properties. Indeed, it has recently been demonstrated that
when introduced into Dgcr8-knockout cells, let-7 rescues the
capacity to silence the self-renewal program under differentia-
tion conditions (Melton et al., 2010). It was found that let-7
induces the differentiation of mouse ESCs by directly targeting
the expression of several stemness factors, including c-Myc,
Sall4, and Lin28, all of which have let-7 binding sites in their
30UTR (Melton et al., 2010). Remarkably, wild-type ESCs were
found to be resistant to let-7-induced suppression of self-
renewal. Moreover, cointroduction of the ESCC miRNAs of the
miR-290 family inhibited the capacity of let-7 to silence self-
renewal in Dgcr8-knockout cells. Though the mechanism under-
lying this phenomenon remains unaddressed, it is assumed that
the ESCC miRNAs repress expression of an unidentified key
factor (or factors) that would otherwise repress expression of
certain stemness factors including c-Myc and Lin28 and that
persistent expression of the stemness factors somehow makes
these cells resistant to the differentiation-promoting action of
let-7. It is likely that c-Myc plays an important role in this
miRNA-mediated cell fate switch because, unlike wild-type
ESCs, c-Myc/ ESCs respond to introduction of let-7 miRNA
and (at least partially) downregulate expression of pluripotency
genes (Melton et al., 2010). Furthermore, expression of Lin28 is
regulated directly by transcriptional activation by c-Myc. These
studies indicate that the let-7 miRNA family opposes the function
of ESCC miRNAs by repressing expression of many of the same
downstream target genes that are indirectly activated by the
ESCC miRNAs. These findings form the basis of a model
proposing that different types of miRNA have opposing effects
on the fate of ESCs: one type (ESCC miRNAs) promotes self-
renewal and antagonizes differentiation and the other (let-7
family) promotes differentiation. The role of miRNAs in theregulation of cell fate decisions is discussed further in an accom-
panying minireview (Ivey and Srivastava, 2010).
miRNAs Control the Expression of Pluripotency Factors
Other miRNAs besides let-7 contribute to the restricted expres-
sion of pluripotency factors during stem cell differentiation.
A study in murine ESCs has uncovered evidence for the miR-
134-, miR-296-, and miR-470-mediated regulation of the pluripo-
tency factors Nanog, Oct4, and Sox2 (Tay et al., 2008). In addition,
work by Wellner and colleagues has shown that miR-200c, miR-
203, and miR-183 cooperate to repress the pluripotency factors
Sox2 and Klf4 in mouse ESCs (Wellner et al., 2009). Introduction
of these miRNAs into undifferentiated ESCs was shown to upre-
gulate differentiation markers and reduce the ability to self-renew.
Likewise, miR-145 reportedly represses the pluripotency
machinery of human ESCs (Xu et al., 2009). Enforced expression
of miR-145 in human ESCs was shown to block self-renewal and
induce expression of differentiation markers. Conversely, inhibi-
tion of miR-145 by the introduction of antisense oligonucleotides
was shown to increase the self-renewal capabilities of human
ESCs. In a double negative feedback circuit, OCT4 transcription-
ally represses miR-145 expression. Oct4/Sox2/Nanog/Tcf3
similarly occupy a set of several different miRNA genes that are
transcriptionally silenced in ESCs and are selectively activated
in particular differentiated cell types. The promoter regions of
these miRNA genes are co-occupied by repressive Polycomb
group proteins and are associated with the inactive histone modi-
fication, H3K27me3, that is catalyzed by Polycomb group pro-
teins (Marson et al., 2008). The observation that multiple miRNAs
target the ESC transcriptional network to promote cell differentia-
tion could reflect a functional reinforcement to commit to the
differentiated state. Alternatively, it could reflect a commitment
driven by each miRNA to differentiate along different develop-
mental pathways or during different time periods.
The Role of miRNAs in Cell Reprogramming
Reprogramming to iPSCs is an inefficient process typically
achieved by the introduction of the key pluripotency transcrip-
tion factors Oct4 and Sox2 into somatic cells. Other stemness
factors such as Klf4, c-Myc, Lin28, and Nanog, although not
essential, can markedly increase the efficiency of reprogram-
ming (Takahashi and Yamanaka, 2006; Yu et al., 2007). Recently,
miRNAs were found to play a role in reprogramming fibroblasts
to iPSCs (Judson et al., 2009). Mouse ESCC miRNAs were found
to enhance the efficiency of Klf4-, Oct4-, and Sox2-induced
reprogramming to an extent similar to c-Myc. Although the
mechanism for how ESCC miRNAs can replace c-Myc in reprog-
ramming is not entirely clear, it has been shown that ESCC
miRNAs are directly upregulated by c-Myc (in combination
with other core transcription factors), suggesting that they are
downstream effectors of c-Myc-promoted pluripotency (Marson
et al., 2008). Accordingly, these miRNAs did not further enhance
reprogramming in the presence of c-Myc. However, unlike exog-
enous c-Myc, these miRNAs induced a homogeneous popula-
tion of reprogrammed colonies, suggesting overlapping and
independent functions of c-Myc and the miRNAs during induced
pluripotency (Judson et al., 2009). It seems likely that the main
contribution of ESCC miRNAs in cell reprogramming is to
promote cell cycle progression. Conversely, suppression of theCell Stem Cell 7, July 2, 2010 ª2010 Elsevier Inc. 33
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Figure 1. Regulatory Circuits Controlling ESC Identity
miRNAs are an integral part of the gene networks that regulate
self-renewal and pluripotency of mouse embryonic stem cells
(ESCs). Rectangles, proteins; diamonds, miRNAs; arrows,
activation; blunted arrows, repression.
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modestly enhance reprogramming of mouse fibroblasts to
iPSCs, highlighting the potential importance of this miRNA family
in maintaining the differentiated state (Melton et al., 2010). These
studies suggest that manipulation of miRNA levels might be
a plausible route for generating iPSCs.
Regulation of let-7 miRNA Biogenesis by Lin28
As previously discussed, let-7 miRNA is an important regulator of
stem cell differentiation. It was recently identified that ESCs
possess an elaborate control mechanism to restrict expression
of let-7. Earlier reports indicated that the expression of let-7
miRNA is regulated posttranscriptionally during mouse embry-
onic development and during differentiation of mouse ESCs.
Indeed, mature let-7 family miRNAs (let-7-a1, -a2, -a3, -b, -c,
-d, -e, -f1, -f2, -g, -i, and miR-98) are undetectable in ESCs
and strongly accumulate 10 days after the onset of differentia-
tion, whereas the corresponding pri-let-7 transcripts (from which
the mature let-7 miRNAs derive) are readily detectable in both
ESCs and differentiated cell types. The developmentally regu-
lated RNA-binding protein Lin28 was recently identified as an
inhibitor of let-7 expression (Viswanathan et al., 2008). Lin28
and Lin28B are orthologs of C. elegans LIN-28, a gene required
for normal cell fate transitions and embryonic developmental
timing. These proteins contain an N-terminal cold shock domain
(CSD) and two Cys-Cys-His-Cys (CCHC)-type zinc fingers in the
C terminus of the protein. Indeed, both domains seem to be
required for RNA binding and Lin28 function. Lin28 and Lin28B
selectively bind to let-7 precursor RNAs and inhibit the expres-
sion of the let-7 family (reviewed by Winter et al., 2009).
How does Lin28 inhibit the maturation of let-7 miRNA? Though
it was found that Lin28-binding to let-7 precursor RNAs can34 Cell Stem Cell 7, July 2, 2010 ª2010 Elsevier Inc.inhibit the in vitro cleavage activity of both the
Microprocessor and Dicer, it seems likely that the
mechanism in vivo is more complex (Winter et al.,
2009). Recently, Narry Kim’s group and our labora-
tory independently identified a 30 terminal uridylyl
transferase (TUTase) that functions together with
Lin28 to catalyze the addition of a short stretch of
uridines to the 30-end of the Lin28-bound pre-let-
7 RNAs. This TUTase, called Zcchc11 (also known
as TUT4), was identified as the enzyme responsible
for the posttranscriptional modification of pre-let-7
RNA (Hagan et al., 2009; Heo et al., 2009).
Zcchc11/TUT4 is a cytoplasmic TUTase that
contains two poly(A) polymerase domains, a nucle-
otidyltransferase domain and several CCHC-type
zinc finger domains. It belongs to a family of non-
canonical poly(A) polymerases. Lin28 recruits
Zcchc11/TUT4 to pre-let-7, and this oligouridyla-
tion activity is required for the blockade of let-7
maturation in ESCs. It is currently not clear howthe Zcchc11/TUT4-mediated oligouridylation of pre-let-7 inhibits
let-7 biogenesis, but the current model implicates an unidentified
ribonuclease that recognizes oligo(U) tails as a signal inducing
pre-let-7 degradation, similar to the mechanism reported for
histone H1 mRNA turnover (Winter et al., 2009).
What is the role of Lin28 in establishing and maintaining ESC
identity? The observations reported by Melton and colleagues
whereby the differentiation-promoting effects of let-7 are antag-
onized by expression of ESCC miRNAs may explain the very
subtle effects on the differentiation status of ESCs upon Lin28
depletion. Despite an accumulation of mature let-7 miRNAs in
these conditions, cell differentiation (as measured by the persis-
tent expression of pluripotency markers) was largely unaffected
(Melton et al., 2010; Viswanathan et al., 2008; Hagan et al.,
2009; Heo et al., 2009). Interestingly, however, one of the first
studies reporting the derivation of human of iPSCs utilized
a slightly different cocktail of factors (Oct4, Sox2, Nanog, and
Lin28) than had been used previously for the reprogramming of
mouse fibroblast cells (Yu et al., 2007; Takahashi and Yamanaka,
2006). This observation, together with the recent report that
antagonizing let-7 enhances cellular reprogramming, indicates
that Lin28-mediated inhibition of let-7 expression promotes cell
dedifferentiation during reprogramming (Melton et al., 2010).
Indeed, it was found that Lin28 accelerates reprogramming
through a predominately cell-division-rate-dependent mecha-
nism (Hanna et al., 2009).
Perspectives
Recent studies have begun to uncover details of complicated
miRNA gene regulatory networks that are essential for ESC
self-renewal and proliferation (Figure 1). Further investigation of
the mechanisms underlying self-renewal and pluripotency of
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normal embryonic development but also somatic cell reprog-
ramming and oncogenesis. Identification of additional stemness
factors as well as genes and pathways regulated by miRNAs will
be exciting areas of future pursuit. It will therefore be important to
identify the mechanisms and factors controlling miRNA expres-
sion both at the transcriptional as well as the posttranscriptional
level. Intriguingly, it was recently found that expression of a large
cluster of (>50) miRNAs encoded within the imprinted Dlk1-Dio3
gene cluster on mouse chromosome 12 uniquely distinguishes
most iPSCs from ESCs. This gene cluster is actively expressed
in ESCs and pluripotent iPSCs but is silenced in iPSC clones
with incomplete epigenetic remodeling and compromised devel-
opmental potential (Stadtfeld et al., 2010). It will be interesting to
determine which, if any, of these many miRNAs may be critical
for ESC and iPSC pluripotency and to identify the corresponding
target genes.
Based on the notable similarities between the rapid cell divi-
sion of undifferentiated ESCs and the inappropriately shortened
cell cycle and abnormal cell growth associated with tumorigen-
esis, it is perhaps not surprising that numerous miRNA-based
mechanisms are shared between stem cells and cancer. For
example, ESCC miRNAs share a common seed sequence with
a larger family of miRNAs (dubbed onco-miRs) known to
promote cellular proliferation, including members of the miR-
17-92 cluster and miR-106 (Esquela-Kerscher and Slack,
2006). These onco-miRs, like the ESCC miRNAs, may be acting
by enhancing cell cycle progression and promoting cell dediffer-
entiation. Further evidence of the parallels between ESCs and
cancer is provided by the expression of the pluripotency factors
Lin28 and Lin28B in a subset of tumors. Indeed, oncogenic
Lin28B and, less frequently, Lin28 are re-expressed in several
cancer types, which is accompanied by reduced let-7 levels.
This model is consistent with the fact that let-7 family members
act as tumor suppressors by repressing known oncogenes
including c-Myc, Hmga2, and Ras (Esquela-Kerscher and Slack,
2006). Thus, approaches involving manipulation of miRNA
activity, i.e., small molecules to inhibit or promote miRNA func-
tion, may constitute alternative strategies to treat cancer, to
improve the efficiency of cell reprogramming, and/or to drive
ESC differentiation into particular cell types.
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